Moderna stock gains on rising flu cases
-- Shares of Moderna (NASDAQ:MRNA) and CureVac (NASDAQ:CVAC) are climbing in Tuesday's premarket trading as seasonal flu cases in the United States show a marked...
-- Shares of Moderna (NASDAQ:MRNA) and CureVac (NASDAQ:CVAC) are climbing in Tuesday's premarket trading as seasonal flu cases in the United States show a marked...
(Reuters) - Meta is ending its fact-checking program in the U.S. and replacing it with a "Community Notes" system similar to that on Elon Musk-owned X, the Facebook (NASDAQ:META)...
(Reuters) -Southwest Airlines said on Tuesday it had entered into a deal to sell and lease back 36 of its Boeing (NYSE:BA) 737-800 aircraft from Babcock & Brown Aircraft...
– Saudi Arabia stocks were higher after the close on Tuesday, as gains in the Insurance, Telecoms & IT and Transport sectors led shares higher. At the close in Saudi...
-- The euro area's Harmonized Index of Consumer Prices (HICP) inflation matched expectations in December, with a year-over-year increase of 2.44% and a...
Zillow (Z, ZG) has unveiled its predictions for the top five housing markets in 2025, with Buffalo, New York securing the leading position. Indianapolis, Indiana takes second place, followed by Providence, Rhode Island in third. Hartford, Connecticut and Philadelphia, Pennsylvania complete the rankings. Wealth host Brad Smith examines Zillow's hot market criteria and what these predictions signal for the broader housing market. To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Angel Smith
(Reuters) -Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its initial public offering in the United States, aiming to...
-- The U.S. Department of Defense has added Chinese tech giants Tencent and CATL to its blacklist, alleging ties to China's military. The move, which has stirred...
By Johann M Cherian and Sukriti Gupta (Reuters) -U.S. stock index futures were trading flat on Tuesday ahead of a set of economic data, with investors looking for any insights on...
-- Shares of Immuneering Corporation (NASDAQ:IMRX) surged 55% following the release of encouraging data from its ongoing Phase 2a trial of IMM-1-104, a therapy for...